The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.
Invesco Nasdaq Biotechnology ETF IBBQ
Morningstar’s Analysis IBBQ
Will IBBQ outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 49.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Gilead Sciences Inc | 8.60 | 3.1 Mil | Healthcare |
Amgen Inc | 7.90 | 2.8 Mil | Healthcare |
Regeneron Pharmaceuticals Inc | 7.85 | 2.8 Mil | Healthcare |
Vertex Pharmaceuticals Inc | 7.81 | 2.8 Mil | Healthcare |
Moderna Inc | 4.43 | 1.6 Mil | Healthcare |
AstraZeneca PLC ADR | 3.63 | 1.3 Mil | Healthcare |
Biogen Inc | 3.22 | 1.2 Mil | Healthcare |
Alnylam Pharmaceuticals Inc | 2.93 | 1.0 Mil | Healthcare |
Illumina Inc | 1.82 | 651,367 | Healthcare |
Biomarin Pharmaceutical Inc | 1.58 | 566,520 | Healthcare |